172 related articles for article (PubMed ID: 20193682)
1. Pyrimethamine induces oxidative stress in Plasmodium yoelii 17XL-infected mice: a novel immunomodulatory mechanism of action for an old antimalarial drug?
Legorreta-Herrera M; Retana-Ugalde R; Ventura-Gallegos JL; Narváez V
Exp Parasitol; 2010 Nov; 126(3):381-8. PubMed ID: 20193682
[TBL] [Abstract][Full Text] [Related]
2. Immunomodulatory role of chloroquine and pyrimethamine in Plasmodium yoelii 17XL infected mice.
Ramos-Avila A; Ventura-Gallegos JL; Zentella-Dehesa A; Machuca-Rodríguez C; Moreno-Altamirano MM; Narváez V; Legorreta-Herrera M
Scand J Immunol; 2007 Jan; 65(1):54-62. PubMed ID: 17212767
[TBL] [Abstract][Full Text] [Related]
3. Status of hepatic oxidative stress and antioxidant defense systems during chloroquine treatment of Plasmodium yoelii nigeriensis infected mice.
Siddiqi NJ; Alhomida AS
In Vivo; 1999; 13(6):547-50. PubMed ID: 10757052
[TBL] [Abstract][Full Text] [Related]
4. Antagonist effect of chloroquine and tumor necrosis factor on hepatic oxidative stress and antioxidant defense in normal and Plasmodium yoelii nigeriensis-infected mice.
Siddiqi NJ; Alhomida AS; Dutta GP; Pandey VC
In Vivo; 2002; 16(1):67-70. PubMed ID: 11980364
[TBL] [Abstract][Full Text] [Related]
5. Different responses of three rodent Plasmodia species, Plasmodium yoelii 17XL, P. berghei NK65 and P. chabaudi AS on treatment with febrifugine and isofebrifugine mixture from Hydrangea macrophylla var. Otaksa leaf in ICR mice.
Ishih A; Miyase T; Ohori K; Terada M
Phytother Res; 2003 Jun; 17(6):650-6. PubMed ID: 12820234
[TBL] [Abstract][Full Text] [Related]
6. Plasmodium yoelii: influence of antimalarial treatment on acquisition of immunity in BALB/c and DBA/2 mice.
Ma SH; Zheng L; Liu YJ; Guo SY; Feng H; Chen G; Li DM; Wang JC; Cao YM
Exp Parasitol; 2007 Jul; 116(3):266-72. PubMed ID: 17336298
[TBL] [Abstract][Full Text] [Related]
7. Plasmodium yoelii: assessment of production and role of nitric oxide during the early stages of infection in susceptible and resistant mice.
Wang QH; Liu YJ; Liu J; Chen G; Zheng W; Wang JC; Cao YM
Exp Parasitol; 2009 Mar; 121(3):268-73. PubMed ID: 19109953
[TBL] [Abstract][Full Text] [Related]
8. Plasmodium yoelii: activity of azithromycin in combination with pyrimethamine or sulfadoxine against blood and sporozoite induced infections in Swiss mice.
Neerja J; Puri SK
Exp Parasitol; 2004; 107(3-4):120-4. PubMed ID: 15363937
[TBL] [Abstract][Full Text] [Related]
9. Comparative histopathology of mice infected with the 17XL and 17XNL strains of Plasmodium yoelii.
Fu Y; Ding Y; Zhou TL; Ou QY; Xu WY
J Parasitol; 2012 Apr; 98(2):310-5. PubMed ID: 22017443
[TBL] [Abstract][Full Text] [Related]
10. Studies on hepatic mitochondrial cytochrome P-450 during Plasmodium yoelii infection and pyrimethamine treatment in mice.
Srivastava P; Pandey VC
Ecotoxicol Environ Saf; 2000 May; 46(1):19-22. PubMed ID: 10805988
[TBL] [Abstract][Full Text] [Related]
11. Prolonged ethanol administration depletes mitochondrial DNA in MnSOD-overexpressing transgenic mice, but not in their wild type littermates.
Larosche I; Choumar A; Fromenty B; Lettéron P; Abbey-Toby A; Van Remmen H; Epstein CJ; Richardson A; Feldmann G; Pessayre D; Mansouri A
Toxicol Appl Pharmacol; 2009 Feb; 234(3):326-38. PubMed ID: 19063909
[TBL] [Abstract][Full Text] [Related]
12. Status of ammonia, glutamate, lactate and pyruvate during Plasmodium yoelii infection and pyrimethamine treatment in mice.
Agarwal A; Tripathi LM; Pandey VC
J Commun Dis; 1997 Sep; 29(3):235-41. PubMed ID: 9465528
[TBL] [Abstract][Full Text] [Related]
13. Status of urea and related enzymes during Plasmodium yoelii infection and pyrimethamine treatment in mice.
Agrawal A; Tripathi LM; Pandey VC
Indian J Exp Biol; 1997 Nov; 35(11):1194-7. PubMed ID: 9567749
[TBL] [Abstract][Full Text] [Related]
14. Study on protective immunity against infection of Plasmodium yoelii 17XL in DBA/2 mice.
Zheng W; Liu J; Meng DY; Hu XF; Cao YM
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2006 Feb; 24(1):14-8. PubMed ID: 16866134
[TBL] [Abstract][Full Text] [Related]
15. Effect of poly ICLC treatment on hepatic oxidative stress and antioxidant defense indices in Plasmodium yoelii nigeriensis infected mice.
Siddiqi NJ; Alhomida AS; Maheshwari RK; Pandey VC
In Vivo; 2001; 15(1):77-80. PubMed ID: 11286134
[TBL] [Abstract][Full Text] [Related]
16. The role of free radicals and antioxidative enzymes in erythrocytes and liver cells in the course of Plasmodium berghei and Plasmodium vinckei infection of mice.
Földes J; Matyi A; Matkovics B
Acta Microbiol Immunol Hung; 1994; 41(2):153-61. PubMed ID: 7804719
[TBL] [Abstract][Full Text] [Related]
17. Improved transfection and new selectable markers for the rodent malaria parasite Plasmodium yoelii.
Jongco AM; Ting LM; Thathy V; Mota MM; Kim K
Mol Biochem Parasitol; 2006 Apr; 146(2):242-50. PubMed ID: 16458371
[TBL] [Abstract][Full Text] [Related]
18. Early treatment during a primary malaria infection modifies the development of cross immunity.
Legorreta-Herrera M; Ventura-Ayala ML; Licona-Chávez RN; Soto-Cruz I; Hernández-Clemente FF
Parasite Immunol; 2004 Jan; 26(1):7-17. PubMed ID: 15198641
[TBL] [Abstract][Full Text] [Related]
19. Antimalarial effects of C18 fatty acids on Plasmodium falciparum in culture and on Plasmodium vinckei petteri and Plasmodium yoelii nigeriensis in vivo.
Krugliak M; Deharo E; Shalmiev G; Sauvain M; Moretti C; Ginsburg H
Exp Parasitol; 1995 Aug; 81(1):97-105. PubMed ID: 7628573
[TBL] [Abstract][Full Text] [Related]
20. Plasmodium berghei: influence of infection on the oxidant and antioxidants levels in pregnant BALB/c mice.
Sharma L; Kaur J; Rishi P; Shukla G
Exp Parasitol; 2012 Jun; 131(2):215-22. PubMed ID: 22542801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
